Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Casellas

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pathologie-Biologie|April 1, 1993
Serum and urinary cefpodoxime levels and time killing curves performed in the urine of children presenting urinary tract infectionsJ M Casellas, G Tome, R Exeni, et al.
Chemotherapy|January 1, 1987
Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolatesC A Barclay, M A Iribarren, M Goldberg, et al.
Infection|May 1, 1990
In vitro activity of cefpirome compared with other third generation cephalosporins against nosocomial isolates in ArgentinaJ M Casellas, M Goldberg, N Orellana, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variantsM Gonzalez Leiza, J C Perez-Diaz, J Ayala, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamaseA Bauernfeind, I Stemplinger, R Jungwirth, et al.
Infection|May 1, 1992
A new plasmidic cefotaximase from patients infected with Salmonella typhimuriumA Bauernfeind, J M Casellas, M Goldberg, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infectionsJ M Casellas, M Gilardoni, G Tome, et al.
Journal of Clinical Microbiology|May 29, 2001
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratoryD L Paterson, W C Ko, A Von Gottberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremiaD L Paterson, L Mulazimoglu, J M Casellas, et al.
Revista Argentina De Microbiologia|July 5, 2005
[Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology]A Famiglietti, M Quinteros, M Vázquez, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pathologie-Biologie|April 1, 1993
Serum and urinary cefpodoxime levels and time killing curves performed in the urine of children presenting urinary tract infectionsJ M Casellas, G Tome, R Exeni, et al.
Chemotherapy|January 1, 1987
Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolatesC A Barclay, M A Iribarren, M Goldberg, et al.
Infection|May 1, 1990
In vitro activity of cefpirome compared with other third generation cephalosporins against nosocomial isolates in ArgentinaJ M Casellas, M Goldberg, N Orellana, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variantsM Gonzalez Leiza, J C Perez-Diaz, J Ayala, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamaseA Bauernfeind, I Stemplinger, R Jungwirth, et al.
Infection|May 1, 1992
A new plasmidic cefotaximase from patients infected with Salmonella typhimuriumA Bauernfeind, J M Casellas, M Goldberg, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infectionsJ M Casellas, M Gilardoni, G Tome, et al.
Journal of Clinical Microbiology|May 29, 2001
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratoryD L Paterson, W C Ko, A Von Gottberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremiaD L Paterson, L Mulazimoglu, J M Casellas, et al.
Revista Argentina De Microbiologia|July 5, 2005
[Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology]A Famiglietti, M Quinteros, M Vázquez, et al.
Pageof 3